Tellus Therapeutics (Series A)
Funding Details
Awarder
Inbox
Date Award
December 13, 2022
Vertical
Neonatal Care
Funding Amount
$35,000,000
Company Info
Founding Year
2018
Founders
Jason Kralic, Eric Benner, Simon Gregory
Market
Newborn Health
Location
USA
Coinvestors
Perceptive, Xontogeny Venture Fund
Company Description

Tellus Therapeutics develops novel small molecules derived from human maternal breast milk.